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Gastric cancer is the one of the most frequent neoplasms of gastrointestinal tract. 
Regarding distribution, there is a rare incidence in people under 30, about 10% of 
patients are under 50; the average mean of patients is between 55 and 65 years. Males 
suffer more from this disease than females - 2:1 proportionally. 
The aim of this paper is to establish the importance of gastroscophy as a reliable 
method for gastric cancer diagnosis as well as to establish the importance of specific 
parameters (sex, macroscopic result) on survival of patients. 
This is a retrospective-prospective study. The study included 70 patients with gastric 
cancer or adenocancer diagnosis. The diagnosis was verified by gastroscophy and patho-
histological result. 
Gastroscophy is a reliable method for gastric cancer diagnosis because early diagnosis is 
of great importance for survival of these patients. Tumor size, lymphnodaly status and 
pathohistological results are of great importance for the type of operative procedure to be 
applied and metastasis as well. Radical lymphodenoctomy with total or subtotal 
gastrectomy increases the survival rate. Acta Medica Medianae 2009;48(4): 10-16. 
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Introduction 
 
Gastric cancer is the most frequent 
malignant neoplasm of the gastrointestinal tract. 
Regarding distribution, there is a rare incidence 
in people under 30, about 10% of patients are 
under 50, and the average age of patients is 
between 55 and 65 years. Males suffer more from 
this disease than females in proportion 2:1 (1). 
In countries such as the US, Japan, Austria 
gastric cancer is the most frequent type of 
digestive tract cancer (1). 
Ethiology of this disease is diverse: eating 
habits, place of living, genetic factors, socio-
economic status of a patient, H. Pylori infection (2). 
Chronical atrophic gastritis together with 
intestinal metaplasion is a predisposition for 
gastric cancer development. Topographical 
frequency of gastric cancer coincides with the 
area of the highest frequency of atrophical 
gastritis and intestinal metaplasion. Antrum and 
lower part of the corpus are places where 
atrophic progression and intestinalisations during 
well-known ’pyloricardial expansion of chronical 
gastritis’ are spread. Total displasion is of the 
lowest risk for gastric cancer development 
considering the fact that incomplete forms of 
metaplasion (type III) are closely related to 
cancer. Studies carried out by Filipe, Munoz and 
Matko in Slovenia, comparing some types of 
intestinal metaplasion, revealed that the type III 
of intestinal metaplasion in comparison to types I 
and II bears only 2.7 to 5.8 times greater risk for 
gastric cancer development; the experience of 
other high risk countries such as Japan and 
Columbia also draws attention to genetic chara-
cteristics of type III of intestinal metaplasion 
(2,3,4). 
On the other hand, anaplastic, mainly 
infiltratively growing cancers malignantly alter 
malignant mutation in reproductive segments of 
gastric glands and not by chronical atrophic 
gastritis allied with IM (intestinal metaplasion) 
(2,3,4). 
Genuine neoplastic polips, adenoms indicate 
pre-cancerous state. Hyperplastic (’regenerative 
polips’ and ’hyperplasiogenic’) polips as well as 
hamarthomatous polips can also alter malignantly 
(2,3,4). 
Chronical peptic ulcer and cancer may be 
present in the stomach and in the same zone of 
atrophic gastritis and intestinal metaplasion. In 
order to differentiate peptic ulcer from cancer, an 
edoscopist must take multiple biopsies in a 
sistematic way from all quadrants, especially 
from proliferative part of ulceration (2). 
Epitel displasion in the zone of chronical 
atrophic gastritis and intestinal-metaplastic gastric 
mucous membrane is an important occurence 
whose stage should be specified; it can be 
graded as light, medium-heavy and heavy 
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has the stage of in citu cancer, Morson debates 
whether this term can be applied to gastric 
mucous membrane changes. Japanese authors 
have discovered that ’intramucous cancer’ is a 
more adeqate term. To this end, it is has been 
recommended not to use the term ’cancer in 
situ’, because it does not correspond with specific 
histological changes (2). 
In patients with pernicious anemia the 
occurence of adenomatous, neoplastic polips and 
gastric cancer has been noticed 3-4 times more 
often than in the rest of the population, in both 
corpus and fundus, that is, places in the stomach 
where atrophic mucous membrane with intestinal 
metaplasion is situated, as opposed to antral and 
pilorous locality of the primal gastric cancer 
without accompanying pernicious anemy (2). 
Gastroscophy-malignant lesion has the look 
of irregular ulcerous lesion whose bottom is 
brownish upon endoscopic examination, edges 
are sapped and irregular, the surrounding tissue 
has pseudopolipoidal infiltration and whose 
mucous membrane is inflexible (5). 
 
AIMS 
 
1.  To establish the importance of gastroscophy 
as a reliable method for gastric cancer 
diagnosis. 
2.  To establish the importance of specific factors 
(sex, macroscopic result) 
3.  To prove that endoscopic result along with 
intraoperative result establishes the type and 
length of cancer operation. 
 
MATERIALS AND METHODS 
 
In this research 70 patients were examined 
and they all had cancer or adenocancer diagnosed 
after gastroscophy and pathohisto-logical verification. 
Thirty-eight of them underwent  radical operation 
(total or subtotal gastrectomy) with systematic 
lymphadenoctomy, 15 of them underwent palliative 
operation for health improvement and 15 
underwent explorative laparothomy for the final 
diagnosis set and possible palliative operation, 
while 2 patients died as a result of generally bad 
health condition after both endoscopic and 
pathohistological diagnosis was made. 
The data are retrospective-prospective, 
collected at Health Care Centre Čačak in Čačak 
(Serbia) for the period between 2003-2006. 
The data comprized diagnostical standard 
for gastric cancer that included: 
•  medical history 
•  clinical examination 
•  la b  a n a ly s e s  ( b lo o d  c o u nt :  HG B , HC T , M VC ,  
Fe) 
•  stomach radiography 
•  gastroscophy with stomach biopsy and 
pathohistological verification (PH) 
•  digitorectal examination (cul de sac pheno-
menon) 
•  radiography of heart, lungs and bone system 
It also included extended diagnostical level 
in clinical conditions; due to clinical evaluation, a 
minimun was added to the following:  
-  stomach endosonography 
-  ultrasound of abdomen, as well as scanner 
(CT) of the abdomen if necessary 
-  liver scintigraphy 
-  tumour markers (CA-50, CA-19-9) 
-  immunological status 
-  laparoscophy 
-  explorative laparothomy 
 
QUESTIONNAIRE  FOR MALIGNANT 
DISEASES 
 
-Full name_________________________ 
-Gender___________ 
-Age___________ 
-Gastroscophy 
-Disease staging (stage of a disease prior to operation-
TNM classification used) 
 
Stage of disease after operation 
-Histological tumor type       Diffuse 
Intestinal 
Unspecified 
-Macroscopic tumor appearance:  
I. Fungal form       
II. Ulcerous form 
II. Ulcerous-Infiltrative form     
IV. Diffuse-Infiltrative form 
-Limphonodal status 
-Operation type : 
1. Radical operation 
2.Palliative operation 
3. Explorative operation 
-Resection type : 
1.Total gastrectomy 
2. Subtotal gastrectomy 
- Outcome: 
1.Alive 
2.Dead 
 
TNM Classification 
 
T1-tumor invasion into mucous or 
submucous membrane, T2-tumor invasion into 
m. propria or subserous layer, T3-tumor 
penetration into serousis, T4-tumor invasion into 
surroinding structures. N0-no evidence of 
metastasis in the lymph node; N1-metastases in 
group 1 of lymph nodes, but there were no 
metastases in groups 2, 3 and 4; N2-metastases 
in group 2 of the lymph nodes, but there were no 
metashases in lymph nodes of groups 3 and 4,  
N3-metashases in groups 3 of lymph nodes, but 
there are no metashases in lymph nodes of group 
4, N4-metasthases in lymph nodes of group 4 P0-
no peritoneal metastases; P1- metastases in the 
surrounding peritoneum, but there were no 
metastases in further peritoneum; P2-a few 
metastases in distant peritoneum; P3-numerous 
metastases in distant peritoneum. Surrounding 
peritoneum: Peritoneum of smaller pouch and 
smaller and larger omentum. Importance of gastroscophy in diagnosis of malignant gastric diseases                                  Aleksandra Ž. Krstić 
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H0-no liver metastases; H1-metastases 
limited to one lobe, H1 (dex)-metastases limited 
to the right lobe, H1 (sin)-metastases limited to 
the left lobe; H2-a few metastases in both lobes; 
H3- numerous metastases in both lobes 
M0-no distant metastases except peritoneal 
and liver metastases 
M1-distant metastases except  peritoneal 
or liver metastases 
M1 category were specified according to 
the following markers: 
Brain (BRA), Bone marrow (MAR), Menings 
(MEN), Bones (OSS), Pleura (PLE), Lungs (PUL), 
Skin (SKI), others (OTH). 
 
Statistic methodology 
 
The obtained data were processed and put 
into tables following discussion, depending on the 
nature of the examined features. 
The description of numerical marks in this 
paper was done with classical methods of 
descriptive statistics with arithemetic mean and 
standard deviation and with minimum and 
maximum value. Also, frequency distributions 
of certain classes within the examined feature 
was represented.  
For the purpose of analysing results and 
depending on the nature of the examined 
features, Pyrson’s hi square test was used in the 
form of compliance tests and contingency tables, 
to compare the difference between frequencies   
with non-parametric features, for one or two 
features. For numerical limitations tables 2 times 
2, Fisher’s test of percise probability was applied. 
In all analytical methods applied, the level 
of importance was <0.05. 
The program of the Institute at Department 
for Medical Statistics and Informatics of the 
University of Belgrade Medical Shool was used for 
bases building and data processing. 
 
Results  
 
In our work 70 patients with gastric cancer 
were examined. 
In Table 1. the main socio-epidemiological 
facts of the patients are showed. The exami-
nation time was 8.5 months on average; average 
age of the examined patients was about 65 
years. 
Analysis of frequency regarding sex showed 
a statistically significant difference (χ
2=7.684; 
df=1; p<0.01), because there were more male 
patients in our study (in proportion to female 
patients 2.5:1). 
In Table 2. frequency of patients in relation 
to tumor locality and metastases presence is 
showed. Analysis of frequency of patients 
regarding tumor locality showed a statistically 
important significant difference (χ
2=8.112; df=3; 
p<0.01), because there were far more patients 
with tumor in antro-piloric part of the stomach in 
comparison to other body parts. 
Analysis of frequency of patients regarding 
presence of cancer metastases showed a 
statistically significant difference (χ
2=14.347; 
df=1; p<0.01), because there were far more 
patients with metastasis diagnosed in comparison 
to other results (comprizing about 86% of the 
results). 
 
Table 1. Main socio-epidemiological study facts 
 
Parametres N  Min  Max Median  SD 
Age (years)  70  42,00  86,00  65,10  10,99 
Examination 
time (days) 
70 5,00  730,00 259,08 69,91 
Sex N  %     
Male 50  71,4     
Female 20  28,6     
Total 70  100,0     
 
Table 2. Frequency of patients regarding tumor locality 
and metastases presence 
 
Parametres  N % 
Regio antri et pylori  30 42,9 
Regio cardiae  11 15,7 
Regio pangastrica  10 14,3 
Regio corporis  19 27,1 
Locality 
 
Total  70 100,0 
 10  14,3 
Not present  60 85,7  Metastases 
Present  70 100,0 
 
Table 3. Frequency of patients according to 
macroscopic tumor look 
 
Groups N  % 
Ulcerous-
infiltrative 
31 44,3 
Diffuse-
infiltrative 
28 40,0 
Ulcerous 7 10,0 
Fungal form  4  5,7 
Total 70  100,0 
Macroscopic 
tumor look 
Ulcerous-
infiltrative 
31 44,3 
 
Table 4. Frequency of patients according to T tumor 
classification before therapy 
 
Groups N  % 
T1 2 3,9 
T2 7  12,0 
T3 30  44,9 
T4 25  37,  7 
T tumor 
classification 
before therapy 
Total 64 100,0 
 
Table 5. Frequency of patients according to N tumor 
classification before therapy 
 
Groups  N % 
N0 11  16,7 
N1 27  40,  9 
N2 9  13,6 
N3 18  27,  3 
N4 1 1,5 
N tumor 
classification 
before therapy 
Total 66 100,0 Acta Medica Medianae 2009,Vol.48(4)                                   Importance of gastroscophy in diagnosis of malignant gastric diseases 
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Table 6. Frequency of patients according to P tumor 
classification before therapy 
 
Groups N  % 
P0 51  77,  3 
P1 1  1,5 
P3 14  21,2 
P tumor 
classification 
before 
therapy  Total 66  100,0 
 
Table 7. Frequency of patients according to H tumor 
classification before therapy 
 
Groups N  % 
H0 52  78,8 
H1 3  4,5 
H3 11  16,7 
H tumor 
classification 
before 
therapy  Total 66  100,0 
 
Table 8. Frequency of patients according to M tumor 
classification before therapy 
 
Groups N  % 
M0 53  80,  3 
M1 10  15,2 
M2 3  4,5 
M tumor 
classification 
before therapy 
Total 66  100,0 
 
Table 9. Frequency of patients according to PH tumor 
result 
 
Groups N  % 
Intestinal 42  61,8 
Diffuse 26  38,2 
Ph tumor 
result 
Total 68  100,0 
 
Table 10. Frequency of patients according to definite T 
tumor result 
 
Groups N  % 
T0 38 57,  6 
T2 3  4,5 
T3 5 7,  6 
T4 20 30,  3 
Definitive T 
tumor stage 
Total 66  100,0 
 
In Table 3. frequency of patients regarding 
macroscopic tumor appearance.  
Analysis of distribution of our patients 
regarding macroscopic tumor appearance shows 
that there is statistically significant difference 
(χ
2=12.677; df=3; p<0.01), and this is because 
there were far more patients with ulcerous and 
diffuse-infiltrative types in comparison to other 
results ( they add up to 85% of the results). 
In Table 4, frequency of patients according 
to T tumor classification before therapy is 
showed. Analysis of frequency of our patients 
according to T tumor classification before therapy 
showed a statistically significant difference 
(χ
2=8.342; df=3; p<0.01), because there were 
far more patients with T result 3 and 4 in 
comparison to other results (comprizing about 
82% of the results). It is interesting that T0 classi- 
 
fication was not found in our group. In Table 5, 
frequency of patients according to N tumor 
classification before therapy is showed. Analysis 
of frequency of patients according to N tumor 
classification before therapy showed a statistically 
significant difference (χ
2=11.049; df=4; p<0.01), 
because there were far more patients with N 
result 0 and 1 in comparison to other results 
(these two stages comprize about 58% of the 
results).  
In table 6, frequency of patients according 
to P tumor classification before therapy is 
showed. Analysis of frequency of patients 
according to the result of P tumor classification 
before therapy shows a statistically significant 
difference (χ
2=23.648; df=2; p<0.01), because 
there were far more patients with P result 0 and 
3 in comparison to other results (these two 
stages comprize about 98% of the results). There 
were no patients with P2 stage. 
In Table 7, frequency of patients according 
to H tumor classification before therapy is 
showed. Analysis of frequency of patients 
according to the result of H tumor classification 
before therapy shows a statistically significant 
difference (χ
2=22.944; df=2; p<0.01), because 
there were far more patients with H result 0 and 
3 in comparison to other results (these two about 
about 95% of the results). There were no 
patients with H2 stage. 
In Table 8, frequency of patients according 
to M tumor classification before therapy is 
showed. Analysis of frequency of patients 
according to the result of M tumor classification 
before therapy showed a statistically significant 
difference (χ
2=24.014; df=2; p<0.01), and there 
were far more patients with M result 0 and 1 in 
comparison to other results (these two stages 
comprize about 95% of the results).  
In Table 9, frequency of patients according 
to PH tumor result is showed. Analysis of 
frequency of  patients according to PH tumor 
result showed a statistically significant difference 
(χ
2=4.628; df=1; p<0.05), because there were 
far more patients with intestinal tumor in 
comparison to diffuse. 
In Table 10, frequency of patients 
according to definite T tumor result is showed. 
Analysis of frequency of patients according to 
definite result of T tumor classification shows a 
statistically significant difference (χ
2=13.074; 
df=3; p<0.01), because there were far more 
patients with T result 0 and 4 in comparison to 
other results (these two stages comprize about 
88% of the results). It is interesting that T1 
classification was not found in our group. 
In Table 11, frequency of patients according 
to definite N tumor classification is showed. 
Analysis of frequency of patients according to 
definite result of N tumor classification shows a 
statistically significant difference (χ
2=12.884; 
df=4; p<0.01), because there were far more 
patients with N result 0 and 3 in comparison to 
other results (these two stages comprize about 
81% of the results).  
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Table 11. Frequency of patients according to definite N 
tumor classification 
 
Groups N  % 
N0 37  56,1 
N1 7  10,  6 
N2 5 7,  6 
N3 16  24,2 
N4 1 1,5 
Definitive N 
tumor stage 
Total 66  100,0 
 
Table 12. Frequency of patients according to definite P 
tumor classification 
 
Groups N  % 
P0 51  77,  3 
P1 2  3,0 
P3 13  19,7 
Definitive P 
tumor stage 
Total 66  100,0 
 
Table 13. Frequency of patients according to definite H 
tumor classification 
 
Groups N  % 
H0 52  78,8 
H1 2 3,0 
H3 12  18,2 
Definitive H tumor 
stage 
Total 66  100,0 
  
Table 14. Frequency of patients according to definite M 
tumor classification 
 
Groups N  % 
0 57  86,4 
1 6  9,1 
2 3  4,5 
Definitive M tumor stage 
Total 66  100,0 
 
Table 15. Frequency of patients regarding operation 
type and therapy outcome 
 
Parametres N  % 
Palliative 15  22,1 
Explorative 
laparothomy 
15 22,1 
Radical 38  55,9 
Operation type 
Total 68  100,0 
 N  % 
Alive 26  37,1 
Dead 44  62,9 
Therapy outcome 
Total 70  100,0 
 
In Table 12, frequency of patients 
according to definite P tumor classification is 
showed. Analysis of frequency of patients 
according to definite result of P tumor 
classification shows a statistically significant 
difference (χ
2=12.884; df=4; p<0.01), because 
there were far more patients with P result 0 and 
3 in comparison to other results (these two 
stages comprize about 97% of the results).  
In Table 13, frequency of patients according 
to definite result of H tumor classification is 
showed. Analysis of frequency of patients according 
to definite result of H tumor classification shows 
a statistically significant difference (χ
2=12.884; 
df=4; p<0.01), because there were far more 
patients with H result 0 and 3 in comparison to 
other results (these two stages comprize to about 
97% of the results). 
In Table 14, frequency of patients according 
to definite M tumor classification is showed. 
Analysis of frequency of patients according to 
definite result of P tumor classification shows a 
statistically significant difference (χ
2=12.884; df=4; 
p<0.01), because there were far more patients 
with M stage 0 in comparison to other results 
(this stage comprize to about 87% of the 
results). 
In Table 15, frequency of patients 
regarding type of tumor operation is showed. 
Analysis of distribution of patients regarding 
operation type used in tumor therapy shows a 
statistically significant difference (χ
2=6.375; 
df=2; p<0.01), because there were far more 
patients who underwent radical operation in 
comparison to other results (this operation type 
comprizes to about 56% of the results).  
Analysis of frequency of patients regarding 
therapy outcome shows a statistically significant 
difference (χ
2=4.997; df=1; p<0.05), because 
there were far more patients who died in 
comparison to those who survived. 
 
Discussion 
 
Seventy patients with malignancies (cancer 
and adenocancer) were examined, 50 males and 
20 females. This is a statistically significant 
difference, because of a larger number of male 
patients that is in accordance with corresponds to 
world literature (2,5). 
In numerous examinations of cancers and 
adenocancers there was no statistically significant 
difference. 
Examination of patients frequency 
regarding tumor locality (antro-piloric part, cardia 
region, pangastric region and corporal part) 
showed a statistically significant difference, due 
to the fact that there were far more patients with 
tumor in antro-piloric part of the stomach in 
comparison to other parts, that is in accordance 
with world data (3,4,5). 
Frequency analysis of patients for macro-
scopic tumor occurence showed a statistically 
significant difference, because there were far 
more patients with ulcerous-diffuse infiltrative 
type (6,7) in comparison to other results (they 
comprize about 85%) (3,4). 
Frequency analysis of patients for tumor 
metastases’ presence showed a statistically 
significant difference, because there were far 
more patients with metastasis in comparison to 
other results (positive comprize about 86% of the 
results) (1,3,4). This coincides with the fact that 
even the best organized services, such as Japan, 
discover early gastric cancer in 30% of the cases; 
this means that in most cases patients have 
already developed an advanced stage of gastric 
cancer prior to examination (2,3,4,6,8,9,10). Acta Medica Medianae 2009,Vol.48(4)                                   Importance of gastroscophy in diagnosis of malignant gastric diseases 
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Frequency analysis of patients according to 
T tumor classification before therapy showed a 
statistically significant difference, because there 
were far more patients with T result 3 and 4 in 
comparison to other results 9 (these two stages 
comprize about 82% of the results). It is 
interesting that T0 tumor classification was not 
found in our group of patients. 
Frequency analysis of patients according to 
N tumor classification before therapy showed that 
there was a statistically significant difference, 
because there were far more patients with N 
result 0 and 1 in comparison to other results 9 
(these two stages comprize about 58% of the 
results).  
Frequency analysis of patients according to 
P result of tumor classification before therapy 
showed a statistically significant difference, 
because there were far more patients with N 
result 0 and 3 in comparison to other results 9 
(these two stages comprize about 98% of the 
results). There were no patients with P2 stage. 
Frequency analysis of patients according to 
H result of tumor classification before therapy 
showed a statistically significant difference, 
because there were far more patients with H 
result 0 and 3 in comparison to other results 9 
(these two stages comprize about 95% of the 
results). There were no patients with H2 stage. 
Frequency analysis of patients according to 
M tumor result of classification before therapy 
showed a statistically significant difference, 
because there were far more patients with M 
result 0 and 1 in comparison to other results 9 
(these two stages comprize about 95% of the 
results). There were no patients with H2 stage. 
All the above mentioned facts show that 
even the best organized services discover early 
gastric cancer in 30% of cases (Japan), which 
means that patients have already developed an 
advanced stage of gastric cancer prior to 
examination (2,3,4,6,8,9,10). 
Frequency analysis of patients according to 
PH tumor result showed a statistically significant 
difference, because there were far more patients 
with intestinal tumor in comparison to diffuse 
which which is accordance with data from 
literature (2,10). 
Frequency analysis of patients according to 
definite result of T tumor classification before 
therapy showed a statistically significant difference, 
because there were far more patients with T 
result 0 and 4 in comparison to other results 9 
(these two stages comprize about 88% of the 
results). It is interesting that T1 classification 
was not found in our group. 
Frequency analysis of patients according to 
definite result of N tumor classification before 
therapy showed a statistically significant difference, 
because there were far more patients with N 
result 0 and 3 in comparison to other results 9 
(these two stages comprize about 81% of the 
results).  
Frequency analysis of patients according to 
definite result of P tumor classification before 
therapy showed a statistically highly significant 
difference, because there were far more patients 
with P result 0 and 3 in comparison to other 
results 9 (these two stages comprize about 97% 
of the results).  
Frequency analysis of patients according to 
definite result of H tumor classification before 
therapy showed a statistically significant difference, 
because there were far more patients with H 
result 0 and 3 in comparison to other results 9 
(these two stages comprize about 97% of the 
results).  
Frequency analysis of patients according to 
definite result of M tumor classification before 
therapy showed a statistically significant difference, 
because there were far more patients with M 
result 0 in comparison to other results 9 (this 
stage comprize about 77% of the results).  
Frequency analysis of patients regarding 
operation type used in tumor therapy showed a 
statistically significant difference, because there 
were far more patients who died in comparison to 
those who survived. All given data concide with 
the fact that even the best organized services 
(Japan) discover  early gastric cancer in 30% of 
the cases (2,3,4,6,8,9,10); as far as Europe is 
concerned the number is 10% (source from world 
literature) (2,3,4,6,8,9,10), which coincides with 
the fact that patients with malignant gastric 
disease come for examination at the advanced 
stage, and therefore with fewer possibilities for 
radical treatment resulting in the fatal outcome 
(5,7,11,12). 
 
Conclusions 
 
1.  Gastroscopy is a reliable method for gastric 
cancer diagnosis. 
2. Early gastric cancer diagnosis is of great 
importance for positive outcome in these 
patients. 
3.  Tumor size, as well as, pathological result 
and lymphonodal status have influence on 
radical operative treatment and further 
metastasis. 
4.  Application of radical lympadenoctomy with 
total or subtotal gastrectomy influence 
survival on the large scale expected in 
patients who are still being monitored at 
present, and who are generally in good 
health without signs of recidives. 
5.  Application of radical extensive lymphadeno-
ctomy increases the survival rate. 
6.  Finally, the importance of this study is to 
show how the Health Care Centre operates, 
and how it  keeps up with world trends in this 
a r e a  o f  k n o w l e d g e  i n  m a j o r i t y  o f  c a s e s .
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ULOGA GASTROSKOPIJE U DIJAGNOSTICI MALIGNIH BOLESTI 
ŽELUCA 
 
Aleksandra Ž. Krstić 
 
 
Karcinom želuca je jedna od najčešćih malignih neoplazmi gastrointestinalnog trakta. 
Retko se nalazi kod osoba mlađih od 30 godina, oko 10% obolelih su osobe do 50 godina, 
srednji prosek obolevanja je između 55 i 65 godina. Češće obolevaju muškarci nego žene, 
u odnosu 2:1. 
Cilj rada bio je da se utvrdi značaj gastroskopije kao suverene metode za dijagnostiku 
karcinoma želuca, kao i da se utvrdi značaj pojedinih faktora (pola, makroskopskog 
nalaza) na dužinu preživljavanja bolesnika.  
Podaci su retrospektivno-prospektivni. U ovom radu je obrađivano 70 bolesnika, od 
kojih su svi imali dijagnostikovan karcinom ili adenokarcinom želuca, putem gastroskopije i 
sa patohistološkom verifikacijom. Od toga, 38 bolesnika je operisano radikalnom operacijom 
(totalnom ili subtotalnom gastrektomijom) sa sistemskom limfadenektomijom, kod 15 
bolesnika je urađena palijativna operacija radi poboljšanja kvaliteta života a kod 15 
bolesnika je urađena eksplorativna laparotomija radi postavljanja konačne dijagnoze i 
eventualne palijativne operacije, a dva bolesnika su umrla usled lošeg opšteg zdravstvenog 
stanja nakon postavljana endoskopske i patohistološke dijagnoze. 
Gastrokopija je suverena metoda dijagnostike karcinoma želuca, budući da je rana 
dijagnostika karcinoma želuca od najveće važnosti za povoljan ishod u preživljavanju ovih 
bolesnika. 
Veličina tumora, limfonodalni status, kao i patohistološki nalaz, utiču na radikalnost 
operativnog lečenja i udaljene metastaze. Primena radikalne linfadenektomije sa totalnom 
i subtotalnom gastrektomijom povećava stopu preživljavanja kod bolesnika sa karcinomom 
želuca. Acta Medica Medianae 2009;48(4):10-16. 
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